BSE filing, BSE: 544160. Summary written from the filing by ALFA Finder's alert engine.
Jay Kailash Namkeen Ltd: key numbers
- Share price
- ₹45.96
- Market cap
- ₹22.97 Cr
- Revenue (annual)
- ₹17.46 Cr
- Net profit (annual)
- ₹1.20 Cr
- P/E (TTM)
- 19.1×Sector 38.6×
- Promoter holding
- 20.32%
- FII holding
- 2.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jay Kailash Namkeen Ltd
All →Jay Kailash Namkeen Open Offer
Jay Kailash Namkeen Ltd constituted a Committee of Independent Directors to provide recommendations on the upcoming Open Offer by Mr. Amar Pramod Talwar.
Jay Kailash Namkeen Management Change
Jay Kailash Namkeen Limited has appointed M/s. MRB & Associates as the new statutory auditor. The company also announced various changes in its board of directors.
Jay Kailash Namkeen Annual General Meeting
Jay Kailash Namkeen held its 5th AGM on September 12, 2026, approving the reappointment of Mr. Neel Pujara, the Statutory Auditor, and several new directors.
Jay Kailash Namkeen Annual General Meeting
Jay Kailash Namkeen held its 5th Annual General Meeting on September 12, 2026. Shareholders approved standard items and a preferential equity issuance of Rs. 15.25 Crore.
- Value
- ₹15.25 Cr
Jay Kailash Namkeen Open Offer
Mr. Amar Pramod Talwar announced an open offer to acquire 26% of Jay Kailash Namkeen Limited. This follows a preferential allotment and share swap agreement.
Jay Kailash Namkeen Other Announcement
Jay Kailash Namkeen Limited has sent a communication to shareholders who have not registered their email addresses, providing instructions to access the Annual Report and AGM notice.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.